Menu Search
Equities

Almirall SA

0O9B:LSE

Almirall SA

Actions
  • Price (EUR)8.27
  • Today's Change-0.063 / -0.75%
  • Shares traded3.71k
  • 1 Year change-1.02%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024 16:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

  • Revenue in EUR (TTM)947.57m
  • Net income in EUR-44.90m
  • Incorporated--
  • Employees2.00k
  • Location
    Almirall SARonda General Mitre, 151BARCELONA 08022SpainESP
  • Phone+34 932913000
  • Fax+34 932913681
  • Websitehttps://www.almirall.es/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.